Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 156
9
Diseases
22
Unique genes
0.285
Avg. similarity score
Colpocephaly
Most-connected disease (6 links)
Disease
Searched: Retinal arterial tortuosity
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Retinal arterial tortuosity
Colpocephaly
Familial hematuria-retinal arteriolar tortuosity-contractures syndrome
COL4A1-related disorder
Prion disease
Cerebral microangiopathy
Hereditary angiopathy with nephropathy, aneurysms, and muscle cramps
Dementia in huntington’s disease
Intellectual developmental disorder hypotonia spastic sleep
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Colpocephaly | 6 | 6 | 1 |
| Familial hematuria-retinal arteriolar tortuosity-contractures syndrome | 6 | 6 | 1 |
| Retinal arterial tortuosity | 6 | 6 | 1 |
| COL4A1-related disorder | 5 | 5 | 1 |
| Prion disease | 5 | 5 | 17 |
| Cerebral microangiopathy | 4 | 4 | 4 |
| Hereditary angiopathy with nephropathy, aneurysms, and muscle cramps | 4 | 4 | 2 |
| Dementia in huntington’s disease | 1 | 1 | 2 |
| Intellectual developmental disorder hypotonia spastic sleep | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| COL4A1 | 7 / 9 | Cerebral microangiopathy, COL4A1-related disorder, Colpocephaly, Familial hematuria-retinal arteriolar tortuosity-contractures syndrome and 3 more |
| ANK3 | 2 / 9 | Intellectual developmental disorder hypotonia spastic sleep, Prion disease |
| PRNP | 2 / 9 | Dementia in huntington’s disease, Prion disease |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
None of these pathways reaches significance (all FDR q ≥ 0.05). They’re the best candidates found, but treat them as weak evidence for why this cluster groups together.
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Collagen biosynthesis and modifying enzymes | Reactome | 2 / 67 | 16.3× | 6.59e-3 | 5.28e-2 |
| Threonine catabolism | Reactome | 1 / 4 | 136× | 7.31e-3 | 5.64e-2 |
| Glycerophospholipid biosynthesis | Reactome | 1 / 5 | 109× | 9.13e-3 | 6.54e-2 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | Reactome | 1 / 10 | 54.6× | 1.82e-2 | 9.97e-2 |
| Interaction between L1 and Ankyrins | Reactome | 1 / 13 | 42.0× | 2.36e-2 | 1.15e-1 |
| Sema3A PAK dependent Axon repulsion | Reactome | 1 / 15 | 36.4× | 2.71e-2 | 1.25e-1 |
| Extracellular matrix organization | Reactome | 1 / 15 | 36.4× | 2.71e-2 | 1.25e-1 |
| Anchoring fibril formation | Reactome | 1 / 15 | 36.4× | 2.71e-2 | 1.25e-1 |
| CRMPs in Sema3A signaling | Reactome | 1 / 16 | 34.1× | 2.89e-2 | 1.29e-1 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | Reactome | 1 / 16 | 34.1× | 2.89e-2 | 1.29e-1 |
| Crosslinking of collagen fibrils | Reactome | 1 / 18 | 30.3× | 3.25e-2 | 1.38e-1 |
| Translesion Synthesis by POLH | Reactome | 1 / 19 | 28.7× | 3.43e-2 | 1.42e-1 |
| NCAM1 interactions | Reactome | 1 / 21 | 26.0× | 3.78e-2 | 1.50e-1 |
| Non-integrin membrane-ECM interactions | Reactome | 1 / 24 | 22.7× | 4.31e-2 | 1.62e-1 |
| Laminin interactions | Reactome | 1 / 28 | 19.5× | 5.01e-2 | 1.76e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| response to copper ion | GO:0046688 | 2 / 12 | 142× | 8.67e-5 | 2.72e-3 ✓ sig. |
| positive regulation of protein targeting to membrane | GO:0090314 | 2 / 27 | 62.9× | 4.56e-4 | 9.07e-3 ✓ sig. |
| neuronal action potential | GO:0019228 | 2 / 34 | 50.0× | 7.25e-4 | 1.24e-2 ✓ sig. |
| neuromuscular junction development | GO:0007528 | 2 / 35 | 48.5× | 7.69e-4 | 1.29e-2 ✓ sig. |
| positive regulation of cell communication by electrical coupling | GO:0010650 | 1 / 1 | 849× | 1.18e-3 | 1.67e-2 ✓ sig. |
| L-threonine catabolic process to glycine | GO:0019518 | 1 / 1 | 849× | 1.18e-3 | 1.67e-2 ✓ sig. |
| placenta development | GO:0001890 | 2 / 48 | 35.4× | 1.44e-3 | 1.90e-2 ✓ sig. |
| maintenance of protein location in plasma membrane | GO:0072660 | 1 / 2 | 425× | 2.35e-3 | 2.52e-2 ✓ sig. |
| positive regulation of membrane depolarization during cardiac muscle cell action potential | GO:1900827 | 1 / 2 | 425× | 2.35e-3 | 2.52e-2 ✓ sig. |
| response to antipsychotic drug | GO:0097332 | 1 / 2 | 425× | 2.35e-3 | 2.52e-2 ✓ sig. |
| cellular response to amino acid stimulus | GO:0071230 | 2 / 64 | 26.5× | 2.55e-3 | 2.64e-2 ✓ sig. |
| basal dendrite arborization | GO:0150020 | 1 / 3 | 283× | 3.53e-3 | 3.12e-2 ✓ sig. |
| positive regulation of heparan sulfate proteoglycan biosynthetic process | GO:0010909 | 1 / 3 | 283× | 3.53e-3 | 3.12e-2 ✓ sig. |
| regulation of glutamate receptor signaling pathway | GO:1900449 | 1 / 3 | 283× | 3.53e-3 | 3.12e-2 ✓ sig. |
| regulation of calcium ion import across plasma membrane | GO:1905664 | 1 / 3 | 283× | 3.53e-3 | 3.12e-2 ✓ sig. |